Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Total SA Q1 Profit Down - Quick Facts

RELATED NEWS
Trade TOT now with 

Total SA (TOT: Quote, TTFNF.PK, TTA.L) reported a decline in first-quarter 2012 net income (Group share) to 3.66 billion euros from 3.95 billion euros a year ago. On an adjusted basis, net profit slid to 3.07 billion euros or 1.36 euros per share from last year's 3.10 billion euros or 1.38 euros per share. Expressed in dollars, adjusted net income was down 5%, with adjusted earnings per share declining 6% to $1.78 from $1.89 in the comparable period.

Sales amounted to 51.17 billion euros compared with 46.03 billion euros in the previous year.

Further, the board has decided on April 26,2012 to pay an interim 2012 dividend of 0.57 euros per share on September 27, 2012.

Click here to receive FREE breaking news email alerts for Total SA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.